The Novartis Saga

Landmark verdict gives big boost to cancer patients

Supreme Court rejects Novartis’ plea for patent; green signal for cheaper generic drugs »

End of R&D

‘Ecosystem to encourage innovation does not exist here' »

Artful claims can’t decide patent law: court

The law of patent in India could not be developed on the artful drafting of claims by companies rather than on the intrinsic worth of in...»

Landmark verdict, say pharma bodies

The Indian pharmaceutical industry and health aid agencies have welcomed the judgment of the Supreme Court which has upheld the refusal...»

Right to affordable drugs upheld: activists

“The court has recognised the right of patients to access affordable medicines over profits for big pharma companies” »

We will not yield to pressure to grant patents, says Sharma

Union Commerce and Industry Minister Anand Sharma has termed “historic” the Supreme Court’s rejection of Novartis’ claim for patent for...»

A just order

The Supreme Court order rejecting a plea to grant patent protection for Glivec, a cancer-fighting drug from Novartis, is a landmark. It...»

Shot in the arm for generics, say oncologists

The Supreme Court’s decision to deny Novartis a fresh patent for its anti-leukaemia drug, Glivec/Imatinib, has been hailed as a move tha...»

The Novartis Saga: a timeline

Novartis had sought to overturn a clause in Indian Patents Law that restricts patent protection for newer forms of existing molecules. The c »

NY lawsuit accuses Novartis of health care fraud

The U.S. government has sued Novartis Pharmaceuticals Corp, claiming it gave kickbacks to pharmacies to switch kidney transplant patient...»

Novartis has no reason to complain: Anand Sharma

Stating that Novartis had no reason to complain and everything had been done under the legal process, Commerce and Industry Minister, An...»

Money first, ethics second

After claiming the fruits of painstaking research by public institutions, private collaborators are now influencing pharma pricing mechanism »


More Resources »



Recent Article in News

Anil Kakodkar. Photo: V. Karthikeyan

IITs should be allowed to take decisions: Kakodkar

Noted scientist and former Chairman of the Atomic Energy Commission (AEC) Anil Kakodkar on Saturday said that the Indian Institute of Te... »